Associations of genetically predicted fatty acid levels across the phenome: A mendelian randomisation study
Fatty acids are important dietary factors that have been extensively studied for their implication in health and disease. Evidence from epidemiological studies and randomised controlled trials on their role in cardiovascular, inflammatory, and other diseases remains inconsistent. The objective of th...
Gespeichert in:
| Veröffentlicht in: | PLoS medicine Jg. 19; H. 12; S. e1004141 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Public Library of Science
29.12.2022
Public Library of Science (PLoS) |
| Schlagworte: | |
| ISSN: | 1549-1676, 1549-1277, 1549-1676 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Fatty acids are important dietary factors that have been extensively studied for their implication in health and disease. Evidence from epidemiological studies and randomised controlled trials on their role in cardiovascular, inflammatory, and other diseases remains inconsistent. The objective of this study was to assess whether genetically predicted fatty acid concentrations affect the risk of disease across a wide variety of clinical health outcomes.
The UK Biobank (UKB) is a large study involving over 500,000 participants aged 40 to 69 years at recruitment from 2006 to 2010. We used summary-level data for 117,143 UKB samples (base dataset), to extract genetic associations of fatty acids, and individual-level data for 322,232 UKB participants (target dataset) to conduct our discovery analysis. We studied potentially causal relationships of circulating fatty acids with 845 clinical diagnoses, using mendelian randomisation (MR) approach, within a phenome-wide association study (PheWAS) framework. Regression models in PheWAS were adjusted for sex, age, and the first 10 genetic principal components. External summary statistics were used for replication. When several fatty acids were associated with a health outcome, multivariable MR and MR-Bayesian method averaging (MR-BMA) was applied to disentangle their causal role. Genetic predisposition to higher docosahexaenoic acid (DHA) was associated with cholelithiasis and cholecystitis (odds ratio per mmol/L: 0.76, 95% confidence interval: 0.66 to 0.87). This was supported in replication analysis (FinnGen study) and by the genetically predicted omega-3 fatty acids analyses. Genetically predicted linoleic acid (LA), omega-6, polyunsaturated fatty acids (PUFAs), and total fatty acids (total FAs) showed positive associations with cardiovascular outcomes with support from replication analysis. Finally, higher genetically predicted levels of DHA (0.83, 0.73 to 0.95) and omega-3 (0.83, 0.75 to 0.92) were found to have a protective effect on obesity, which was supported using body mass index (BMI) in the GIANT consortium as replication analysis. Multivariable MR analysis suggested a direct detrimental effect of LA (1.64, 1.07 to 2.50) and omega-6 fatty acids (1.81, 1.06 to 3.09) on coronary heart disease (CHD). MR-BMA prioritised LA and omega-6 fatty acids as the top risk factors for CHD. Although we present a range of sensitivity analyses to the address MR assumptions, horizontal pleiotropy may still bias the reported associations and further evaluation in clinical trials is needed.
Our study suggests potentially protective effects of circulating DHA and omega-3 concentrations on cholelithiasis and cholecystitis and on obesity, highlighting the need to further assess them as prevention treatments in clinical trials. Moreover, our findings do not support the supplementation of unsaturated fatty acids for cardiovascular disease prevention. |
|---|---|
| AbstractList | Fatty acids are important dietary factors that have been extensively studied for their implication in health and disease. Evidence from epidemiological studies and randomised controlled trials on their role in cardiovascular, inflammatory, and other diseases remains inconsistent. The objective of this study was to assess whether genetically predicted fatty acid concentrations affect the risk of disease across a wide variety of clinical health outcomes. The UK Biobank (UKB) is a large study involving over 500,000 participants aged 40 to 69 years at recruitment from 2006 to 2010. We used summary-level data for 117,143 UKB samples (base dataset), to extract genetic associations of fatty acids, and individual-level data for 322,232 UKB participants (target dataset) to conduct our discovery analysis. We studied potentially causal relationships of circulating fatty acids with 845 clinical diagnoses, using mendelian randomisation (MR) approach, within a phenome-wide association study (PheWAS) framework. Regression models in PheWAS were adjusted for sex, age, and the first 10 genetic principal components. External summary statistics were used for replication. When several fatty acids were associated with a health outcome, multivariable MR and MR-Bayesian method averaging (MR-BMA) was applied to disentangle their causal role. Genetic predisposition to higher docosahexaenoic acid (DHA) was associated with cholelithiasis and cholecystitis (odds ratio per mmol/L: 0.76, 95% confidence interval: 0.66 to 0.87). This was supported in replication analysis (FinnGen study) and by the genetically predicted omega-3 fatty acids analyses. Genetically predicted linoleic acid (LA), omega-6, polyunsaturated fatty acids (PUFAs), and total fatty acids (total FAs) showed positive associations with cardiovascular outcomes with support from replication analysis. Finally, higher genetically predicted levels of DHA (0.83, 0.73 to 0.95) and omega-3 (0.83, 0.75 to 0.92) were found to have a protective effect on obesity, which was supported using body mass index (BMI) in the GIANT consortium as replication analysis. Multivariable MR analysis suggested a direct detrimental effect of LA (1.64, 1.07 to 2.50) and omega-6 fatty acids (1.81, 1.06 to 3.09) on coronary heart disease (CHD). MR-BMA prioritised LA and omega-6 fatty acids as the top risk factors for CHD. Although we present a range of sensitivity analyses to the address MR assumptions, horizontal pleiotropy may still bias the reported associations and further evaluation in clinical trials is needed. Our study suggests potentially protective effects of circulating DHA and omega-3 concentrations on cholelithiasis and cholecystitis and on obesity, highlighting the need to further assess them as prevention treatments in clinical trials. Moreover, our findings do not support the supplementation of unsaturated fatty acids for cardiovascular disease prevention. Background Fatty acids are important dietary factors that have been extensively studied for their implication in health and disease. Evidence from epidemiological studies and randomised controlled trials on their role in cardiovascular, inflammatory, and other diseases remains inconsistent. The objective of this study was to assess whether genetically predicted fatty acid concentrations affect the risk of disease across a wide variety of clinical health outcomes. Methods and findings The UK Biobank (UKB) is a large study involving over 500,000 participants aged 40 to 69 years at recruitment from 2006 to 2010. We used summary-level data for 117,143 UKB samples (base dataset), to extract genetic associations of fatty acids, and individual-level data for 322,232 UKB participants (target dataset) to conduct our discovery analysis. We studied potentially causal relationships of circulating fatty acids with 845 clinical diagnoses, using mendelian randomisation (MR) approach, within a phenome-wide association study (PheWAS) framework. Regression models in PheWAS were adjusted for sex, age, and the first 10 genetic principal components. External summary statistics were used for replication. When several fatty acids were associated with a health outcome, multivariable MR and MR-Bayesian method averaging (MR-BMA) was applied to disentangle their causal role. Genetic predisposition to higher docosahexaenoic acid (DHA) was associated with cholelithiasis and cholecystitis (odds ratio per mmol/L: 0.76, 95% confidence interval: 0.66 to 0.87). This was supported in replication analysis (FinnGen study) and by the genetically predicted omega-3 fatty acids analyses. Genetically predicted linoleic acid (LA), omega-6, polyunsaturated fatty acids (PUFAs), and total fatty acids (total FAs) showed positive associations with cardiovascular outcomes with support from replication analysis. Finally, higher genetically predicted levels of DHA (0.83, 0.73 to 0.95) and omega-3 (0.83, 0.75 to 0.92) were found to have a protective effect on obesity, which was supported using body mass index (BMI) in the GIANT consortium as replication analysis. Multivariable MR analysis suggested a direct detrimental effect of LA (1.64, 1.07 to 2.50) and omega-6 fatty acids (1.81, 1.06 to 3.09) on coronary heart disease (CHD). MR-BMA prioritised LA and omega-6 fatty acids as the top risk factors for CHD. Although we present a range of sensitivity analyses to the address MR assumptions, horizontal pleiotropy may still bias the reported associations and further evaluation in clinical trials is needed. Conclusions Our study suggests potentially protective effects of circulating DHA and omega-3 concentrations on cholelithiasis and cholecystitis and on obesity, highlighting the need to further assess them as prevention treatments in clinical trials. Moreover, our findings do not support the supplementation of unsaturated fatty acids for cardiovascular disease prevention. Loukas Zagkos and colleagues conduct Mendelian randomisation analysis to investigate potential causal associations of circulating fatty acids and 845 disease outcomes in the UK Biobank. Author summary Why was this study done? Epidemiological studies have investigated the influence of dietary fatty acids on several chronic diseases including cardiovascular disease (CVD), inflammatory diseases, cancers, and neurodegenerative conditions. The evidence is conflicting and inconclusive and is not supported by randomised controlled trials (RCTs) on fatty acids supplementation. The fact that the human fatty acid metabolome partly reflects the fatty acid intake was leveraged in this work. What did the researchers do and find? Mendelian randomisation analysis was conducted to investigate potential causal associations of circulating fatty acids and 845 disease outcomes in UK Biobank. We found that 1 mmol/L increase in genetically predicted docosahexaenoic acid (DHA) was associated with 24% reduced odds of cholelithiasis and cholecystitis, as well as 17% reduced odds of obesity. One mmol/L higher genetically predicted linoleic acid (LA) was associated with 27% increased odds of ischemic heart disease. When assessed with other fatty acid classes simultaneously, 1 mmol/L higher genetically predicted LA and omega-6 fatty acids were associated with higher odds of coronary heart disease (64% and 81% increase, respectively). What do these findings mean? Our results support the prioritisation of RCTs examining the role of primary and secondary prevention of cholelithiasis via dietary modification or supplementation of DHA and other omega-3 fatty acids. Our principal findings also provide evidence against the supplemental use of fatty acids for CVD prevention. Triangulation of evidence for causal inference of fatty acid levels through experimental studies susceptible to different assumptions is needed to strengthen the evidence. Fatty acids are important dietary factors that have been extensively studied for their implication in health and disease. Evidence from epidemiological studies and randomised controlled trials on their role in cardiovascular, inflammatory, and other diseases remains inconsistent. The objective of this study was to assess whether genetically predicted fatty acid concentrations affect the risk of disease across a wide variety of clinical health outcomes. The UK Biobank (UKB) is a large study involving over 500,000 participants aged 40 to 69 years at recruitment from 2006 to 2010. We used summary-level data for 117,143 UKB samples (base dataset), to extract genetic associations of fatty acids, and individual-level data for 322,232 UKB participants (target dataset) to conduct our discovery analysis. We studied potentially causal relationships of circulating fatty acids with 845 clinical diagnoses, using mendelian randomisation (MR) approach, within a phenome-wide association study (PheWAS) framework. Regression models in PheWAS were adjusted for sex, age, and the first 10 genetic principal components. External summary statistics were used for replication. When several fatty acids were associated with a health outcome, multivariable MR and MR-Bayesian method averaging (MR-BMA) was applied to disentangle their causal role. Genetic predisposition to higher docosahexaenoic acid (DHA) was associated with cholelithiasis and cholecystitis (odds ratio per mmol/L: 0.76, 95% confidence interval: 0.66 to 0.87). This was supported in replication analysis (FinnGen study) and by the genetically predicted omega-3 fatty acids analyses. Genetically predicted linoleic acid (LA), omega-6, polyunsaturated fatty acids (PUFAs), and total fatty acids (total FAs) showed positive associations with cardiovascular outcomes with support from replication analysis. Finally, higher genetically predicted levels of DHA (0.83, 0.73 to 0.95) and omega-3 (0.83, 0.75 to 0.92) were found to have a protective effect on obesity, which was supported using body mass index (BMI) in the GIANT consortium as replication analysis. Multivariable MR analysis suggested a direct detrimental effect of LA (1.64, 1.07 to 2.50) and omega-6 fatty acids (1.81, 1.06 to 3.09) on coronary heart disease (CHD). MR-BMA prioritised LA and omega-6 fatty acids as the top risk factors for CHD. Although we present a range of sensitivity analyses to the address MR assumptions, horizontal pleiotropy may still bias the reported associations and further evaluation in clinical trials is needed. Our study suggests potentially protective effects of circulating DHA and omega-3 concentrations on cholelithiasis and cholecystitis and on obesity, highlighting the need to further assess them as prevention treatments in clinical trials. Moreover, our findings do not support the supplementation of unsaturated fatty acids for cardiovascular disease prevention. Loukas Zagkos and colleagues conduct Mendelian randomisation analysis to investigate potential causal associations of circulating fatty acids and 845 disease outcomes in the UK Biobank. Fatty acids are important dietary factors that have been extensively studied for their implication in health and disease. Evidence from epidemiological studies and randomised controlled trials on their role in cardiovascular, inflammatory, and other diseases remains inconsistent. The objective of this study was to assess whether genetically predicted fatty acid concentrations affect the risk of disease across a wide variety of clinical health outcomes.BACKGROUNDFatty acids are important dietary factors that have been extensively studied for their implication in health and disease. Evidence from epidemiological studies and randomised controlled trials on their role in cardiovascular, inflammatory, and other diseases remains inconsistent. The objective of this study was to assess whether genetically predicted fatty acid concentrations affect the risk of disease across a wide variety of clinical health outcomes.The UK Biobank (UKB) is a large study involving over 500,000 participants aged 40 to 69 years at recruitment from 2006 to 2010. We used summary-level data for 117,143 UKB samples (base dataset), to extract genetic associations of fatty acids, and individual-level data for 322,232 UKB participants (target dataset) to conduct our discovery analysis. We studied potentially causal relationships of circulating fatty acids with 845 clinical diagnoses, using mendelian randomisation (MR) approach, within a phenome-wide association study (PheWAS) framework. Regression models in PheWAS were adjusted for sex, age, and the first 10 genetic principal components. External summary statistics were used for replication. When several fatty acids were associated with a health outcome, multivariable MR and MR-Bayesian method averaging (MR-BMA) was applied to disentangle their causal role. Genetic predisposition to higher docosahexaenoic acid (DHA) was associated with cholelithiasis and cholecystitis (odds ratio per mmol/L: 0.76, 95% confidence interval: 0.66 to 0.87). This was supported in replication analysis (FinnGen study) and by the genetically predicted omega-3 fatty acids analyses. Genetically predicted linoleic acid (LA), omega-6, polyunsaturated fatty acids (PUFAs), and total fatty acids (total FAs) showed positive associations with cardiovascular outcomes with support from replication analysis. Finally, higher genetically predicted levels of DHA (0.83, 0.73 to 0.95) and omega-3 (0.83, 0.75 to 0.92) were found to have a protective effect on obesity, which was supported using body mass index (BMI) in the GIANT consortium as replication analysis. Multivariable MR analysis suggested a direct detrimental effect of LA (1.64, 1.07 to 2.50) and omega-6 fatty acids (1.81, 1.06 to 3.09) on coronary heart disease (CHD). MR-BMA prioritised LA and omega-6 fatty acids as the top risk factors for CHD. Although we present a range of sensitivity analyses to the address MR assumptions, horizontal pleiotropy may still bias the reported associations and further evaluation in clinical trials is needed.METHODS AND FINDINGSThe UK Biobank (UKB) is a large study involving over 500,000 participants aged 40 to 69 years at recruitment from 2006 to 2010. We used summary-level data for 117,143 UKB samples (base dataset), to extract genetic associations of fatty acids, and individual-level data for 322,232 UKB participants (target dataset) to conduct our discovery analysis. We studied potentially causal relationships of circulating fatty acids with 845 clinical diagnoses, using mendelian randomisation (MR) approach, within a phenome-wide association study (PheWAS) framework. Regression models in PheWAS were adjusted for sex, age, and the first 10 genetic principal components. External summary statistics were used for replication. When several fatty acids were associated with a health outcome, multivariable MR and MR-Bayesian method averaging (MR-BMA) was applied to disentangle their causal role. Genetic predisposition to higher docosahexaenoic acid (DHA) was associated with cholelithiasis and cholecystitis (odds ratio per mmol/L: 0.76, 95% confidence interval: 0.66 to 0.87). This was supported in replication analysis (FinnGen study) and by the genetically predicted omega-3 fatty acids analyses. Genetically predicted linoleic acid (LA), omega-6, polyunsaturated fatty acids (PUFAs), and total fatty acids (total FAs) showed positive associations with cardiovascular outcomes with support from replication analysis. Finally, higher genetically predicted levels of DHA (0.83, 0.73 to 0.95) and omega-3 (0.83, 0.75 to 0.92) were found to have a protective effect on obesity, which was supported using body mass index (BMI) in the GIANT consortium as replication analysis. Multivariable MR analysis suggested a direct detrimental effect of LA (1.64, 1.07 to 2.50) and omega-6 fatty acids (1.81, 1.06 to 3.09) on coronary heart disease (CHD). MR-BMA prioritised LA and omega-6 fatty acids as the top risk factors for CHD. Although we present a range of sensitivity analyses to the address MR assumptions, horizontal pleiotropy may still bias the reported associations and further evaluation in clinical trials is needed.Our study suggests potentially protective effects of circulating DHA and omega-3 concentrations on cholelithiasis and cholecystitis and on obesity, highlighting the need to further assess them as prevention treatments in clinical trials. Moreover, our findings do not support the supplementation of unsaturated fatty acids for cardiovascular disease prevention.CONCLUSIONSOur study suggests potentially protective effects of circulating DHA and omega-3 concentrations on cholelithiasis and cholecystitis and on obesity, highlighting the need to further assess them as prevention treatments in clinical trials. Moreover, our findings do not support the supplementation of unsaturated fatty acids for cardiovascular disease prevention. Background Fatty acids are important dietary factors that have been extensively studied for their implication in health and disease. Evidence from epidemiological studies and randomised controlled trials on their role in cardiovascular, inflammatory, and other diseases remains inconsistent. The objective of this study was to assess whether genetically predicted fatty acid concentrations affect the risk of disease across a wide variety of clinical health outcomes. Methods and findings The UK Biobank (UKB) is a large study involving over 500,000 participants aged 40 to 69 years at recruitment from 2006 to 2010. We used summary-level data for 117,143 UKB samples (base dataset), to extract genetic associations of fatty acids, and individual-level data for 322,232 UKB participants (target dataset) to conduct our discovery analysis. We studied potentially causal relationships of circulating fatty acids with 845 clinical diagnoses, using mendelian randomisation (MR) approach, within a phenome-wide association study (PheWAS) framework. Regression models in PheWAS were adjusted for sex, age, and the first 10 genetic principal components. External summary statistics were used for replication. When several fatty acids were associated with a health outcome, multivariable MR and MR-Bayesian method averaging (MR-BMA) was applied to disentangle their causal role. Genetic predisposition to higher docosahexaenoic acid (DHA) was associated with cholelithiasis and cholecystitis (odds ratio per mmol/L: 0.76, 95% confidence interval: 0.66 to 0.87). This was supported in replication analysis (FinnGen study) and by the genetically predicted omega-3 fatty acids analyses. Genetically predicted linoleic acid (LA), omega-6, polyunsaturated fatty acids (PUFAs), and total fatty acids (total FAs) showed positive associations with cardiovascular outcomes with support from replication analysis. Finally, higher genetically predicted levels of DHA (0.83, 0.73 to 0.95) and omega-3 (0.83, 0.75 to 0.92) were found to have a protective effect on obesity, which was supported using body mass index (BMI) in the GIANT consortium as replication analysis. Multivariable MR analysis suggested a direct detrimental effect of LA (1.64, 1.07 to 2.50) and omega-6 fatty acids (1.81, 1.06 to 3.09) on coronary heart disease (CHD). MR-BMA prioritised LA and omega-6 fatty acids as the top risk factors for CHD. Although we present a range of sensitivity analyses to the address MR assumptions, horizontal pleiotropy may still bias the reported associations and further evaluation in clinical trials is needed. Conclusions Our study suggests potentially protective effects of circulating DHA and omega-3 concentrations on cholelithiasis and cholecystitis and on obesity, highlighting the need to further assess them as prevention treatments in clinical trials. Moreover, our findings do not support the supplementation of unsaturated fatty acids for cardiovascular disease prevention. |
| Audience | Academic |
| Author | Dehghan, Abbas Tzoulaki, Ioanna Drenos, Fotios Elliott, Paul Tsilidis, Kostas Dib, Marie-Joe Gill, Dipender Zagkos, Loukas Pinto, Rui Markozannes, Georgios Zuber, Verena Koskeridis, Fotios |
| AuthorAffiliation | 3 Chief Scientific Advisor Office, Research and Early Development, Novo Nordisk, Copenhagen, Denmark 1 Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom 5 Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece 8 BHF Centre of Excellence at Imperial College London, London, United Kingdom Chinese University of Hong Kong, CHINA 2 UK Dementia Research Institute, Imperial College London, London, United Kingdom 7 Institute of Cardiovascular Sciences, University College London, London, United Kingdom 4 Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom 6 Department of Life Sciences, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge, United Kingdom |
| AuthorAffiliation_xml | – name: 4 Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom – name: 3 Chief Scientific Advisor Office, Research and Early Development, Novo Nordisk, Copenhagen, Denmark – name: 6 Department of Life Sciences, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge, United Kingdom – name: 8 BHF Centre of Excellence at Imperial College London, London, United Kingdom – name: Chinese University of Hong Kong, CHINA – name: 5 Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece – name: 7 Institute of Cardiovascular Sciences, University College London, London, United Kingdom – name: 1 Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom – name: 2 UK Dementia Research Institute, Imperial College London, London, United Kingdom |
| Author_xml | – sequence: 1 givenname: Loukas orcidid: 0000-0002-7700-8102 surname: Zagkos fullname: Zagkos, Loukas – sequence: 2 givenname: Marie-Joe orcidid: 0000-0001-7591-5684 surname: Dib fullname: Dib, Marie-Joe – sequence: 3 givenname: Rui orcidid: 0000-0002-8527-4873 surname: Pinto fullname: Pinto, Rui – sequence: 4 givenname: Dipender orcidid: 0000-0001-7312-7078 surname: Gill fullname: Gill, Dipender – sequence: 5 givenname: Fotios orcidid: 0000-0002-1253-7556 surname: Koskeridis fullname: Koskeridis, Fotios – sequence: 6 givenname: Fotios orcidid: 0000-0003-2469-5516 surname: Drenos fullname: Drenos, Fotios – sequence: 7 givenname: Georgios orcidid: 0000-0001-8481-579X surname: Markozannes fullname: Markozannes, Georgios – sequence: 8 givenname: Paul orcidid: 0000-0002-7511-5684 surname: Elliott fullname: Elliott, Paul – sequence: 9 givenname: Verena surname: Zuber fullname: Zuber, Verena – sequence: 10 givenname: Kostas surname: Tsilidis fullname: Tsilidis, Kostas – sequence: 11 givenname: Abbas orcidid: 0000-0001-6403-016X surname: Dehghan fullname: Dehghan, Abbas – sequence: 12 givenname: Ioanna orcidid: 0000-0002-4275-9328 surname: Tzoulaki fullname: Tzoulaki, Ioanna |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36580444$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVk12L1DAUhousuB_6D0QCgujFjEmbaZu9EIbFj4HFBb9uQ5qczGRNk7FJF-ffm-nMylQGUXrRkDzv2-ac95xnJ847yLKnBE9JUZHXt77vnLDTdQtqSjCmhJIH2RmZUTYhZVWeHKxPs_MQbjHOGWb4UXZalLMaU0rPsu_zELw0IhrvAvIaLcFBNFJYu0HrDpSRERTSIsYNEtIoZOEObEjrzoeA4grQegXOt3CJ5qgFp8Aa4VAnnPKtCYMzCrFXm8fZQy1sgCf790X29d3bL1cfJtc37xdX8-uJLGkeJw3QBmtFciwLXFVEUwGMEaZqKBuZY8FwxTBQVmMlEyibGVVlQXKlqpzqorjIFjtf5cUtX3emFd2Ge2H4sOG7JRdduqMFTqpGF02hhawJLUvJKlpKyFUuiVRK6uT1Zue17ptUaAkudsKOTMcnzqz40t9xVjFWkCoZvNwbdP5HDyHyVBQJ1goHvg88r2YsLymdkYQ-36FLkX7NOO2To9zifF4VQ8_qOlGTI9S2benzKSLapO0RPz3Cp0dBa-RRwauRIDERfsal6EPgi8-f_oP9-O_szbcx--KAXYGwcRW87YeYjsFnh_353Zj7hCfgcgcMee1Ac2niEMpUBmM5wXw7Tnw_Tnw7Tnw_TklM_xDf-_9V9gsDYCZX |
| CitedBy_id | crossref_primary_10_1016_j_jpba_2025_117038 crossref_primary_10_3389_fnut_2023_1308622 crossref_primary_10_1080_17474086_2025_2468400 crossref_primary_10_3168_jds_2024_26042 crossref_primary_10_1097_MD_0000000000035127 crossref_primary_10_1016_j_neuroscience_2025_08_050 crossref_primary_10_1007_s00223_024_01228_x crossref_primary_10_1080_01443615_2024_2362415 crossref_primary_10_1080_21505594_2025_2553786 crossref_primary_10_1016_j_clnu_2025_03_020 crossref_primary_10_1007_s12020_024_03714_6 crossref_primary_10_3389_fneur_2024_1338153 crossref_primary_10_2147_DMSO_S528669 crossref_primary_10_2147_COPD_S437257 crossref_primary_10_31083_j_jin2304076 crossref_primary_10_1177_17534666251348393 crossref_primary_10_1177_20420986231224236 crossref_primary_10_1016_j_heliyon_2023_e23118 crossref_primary_10_1007_s40268_024_00474_6 crossref_primary_10_3389_fphar_2024_1382924 crossref_primary_10_1017_S0007114524002095 crossref_primary_10_1016_j_archger_2024_105655 crossref_primary_10_1016_j_clnesp_2025_06_008 crossref_primary_10_1016_j_jpsychores_2024_111994 crossref_primary_10_1007_s12672_025_02248_1 crossref_primary_10_1177_15330338231173495 crossref_primary_10_1111_acel_13868 crossref_primary_10_1186_s12944_023_01989_8 crossref_primary_10_1186_s12877_024_05379_2 crossref_primary_10_1007_s00406_025_02036_6 crossref_primary_10_1016_j_foodchem_2024_141943 crossref_primary_10_1016_j_tjpad_2025_100196 crossref_primary_10_1186_s13098_025_01878_3 crossref_primary_10_1007_s12020_024_03976_0 crossref_primary_10_1038_s41430_024_01486_w crossref_primary_10_18282_po3628 |
| Cites_doi | 10.5539/gjhs.v8n7p18 10.1016/j.ejphar.2011.05.085 10.1186/s12933-018-0740-x 10.1016/j.clnu.2022.02.022 10.1093/hmg/ddy271 10.1161/CIRCULATIONAHA.118.038908 10.1038/s41467-019-13870-3 10.1038/ng.2982 10.1038/s41586-018-0579-z 10.1038/s41588-018-0099-7 10.2337/db10-0502 10.1038/ejcn.2013.197 10.3390/nu11112599 10.1161/CIRCGENETICS.113.000208 10.1111/j.1440-1746.2012.07227.x 10.1038/ncomms11122 10.1136/eb-2012-100960 10.7554/eLife.34408 10.1371/journal.pgen.1002193 10.1038/ng.2897 10.1093/ije/dyv080 10.7326/0003-4819-141-7-200410050-00007 10.1093/ije/dyy262 10.4103/2279-042X.162356 10.1371/journal.pmed.1001779 10.1136/heartjnl-2020-316780 10.1111/j.2517-6161.1995.tb02031.x 10.1016/j.plefa.2014.11.007 10.3945/an.114.006940 10.1161/CIRCGENETICS.112.964619 10.1093/bioinformatics/btu197 10.1016/j.clnesp.2021.04.023 10.1016/j.mayocp.2016.10.018 10.1158/1538-7445.AM2015-3723 10.1038/ng.2802 10.1002/gepi.21965 10.1001/2012.jama.11374 10.1093/aje/kwv017 10.1038/ng.3396 10.1186/s12916-022-02399-w 10.1038/ng.3211 10.1002/hep.1840160418 10.1002/gepi.21758 |
| ContentType | Journal Article |
| Copyright | Copyright: © 2022 Zagkos et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. COPYRIGHT 2022 Public Library of Science 2022 Zagkos et al 2022 Zagkos et al |
| Copyright_xml | – notice: Copyright: © 2022 Zagkos et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. – notice: COPYRIGHT 2022 Public Library of Science – notice: 2022 Zagkos et al 2022 Zagkos et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISN ISR 7X8 5PM DOA |
| DOI | 10.1371/journal.pmed.1004141 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Canada Gale In Context: Science MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ - Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Circulating fatty acids across the phenome: A MR study |
| EISSN | 1549-1676 |
| ExternalDocumentID | oai_doaj_org_article_17bf3b3fac81466c9746ce2d2c1cddcf PMC9799317 A733658088 36580444 10_1371_journal_pmed_1004141 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United Kingdom |
| GeographicLocations_xml | – name: United Kingdom |
| GrantInformation_xml | – fundername: Medical Research Council grantid: MR/ S019669/1 – fundername: Department of Health – fundername: Medical Research Council grantid: MR/W029790/1 – fundername: Medical Research Council grantid: MR/S019669/1 – fundername: Medical Research Council grantid: MR/L01341X/1 – fundername: British Heart Foundation grantid: CFC1007 – fundername: Medical Research Council grantid: MC_PC_17228 – fundername: British Heart Foundation grantid: RE/18/4/34215 – fundername: ; grantid: MC_PC_17114 – fundername: ; grantid: RE/18/4/34215 – fundername: ; grantid: MR/L01341X/1; MR/ S019669/1 – fundername: ; grantid: CFC1007 |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAUCC AAWOE AAWTL AAYXX ABDBF ABUWG ACCTH ACGFO ACIHN ACPRK ACUHS ADBBV AEAQA AENEX AFFHD AFKRA AFPKN AFRAH AFXKF AHMBA AKRSQ ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAIFH BAWUL BBTPI BCNDV BENPR BPHCQ BVXVI BWKFM CCPQU CITATION CS3 DIK DU5 E3Z EAP EAS EBD EBS EJD EMK EMOBN ESX F5P FPL FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR IOF IOV IPO ISN ISR ITC KQ8 M1P M48 MK0 O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PV9 RNS RPM RZL SV3 TR2 TUS UKHRP WOW XSB YZZ ~8M ADRAZ ADXHL ALIPV CGR CUY CVF ECM EIF H13 IPNFZ NPM RIG WOQ 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c642t-be4b0fd120c30771f4ae9919d8e6bc20a90790e4980dc0fdcb54d6312dd724f33 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 40 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000924510300011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1549-1676 1549-1277 |
| IngestDate | Fri Oct 03 12:45:29 EDT 2025 Tue Nov 04 02:07:00 EST 2025 Fri Sep 05 07:08:00 EDT 2025 Tue Nov 11 10:17:22 EST 2025 Sat Nov 29 11:23:25 EST 2025 Tue Nov 04 18:02:48 EST 2025 Wed Nov 26 11:27:58 EST 2025 Thu Nov 13 16:28:41 EST 2025 Wed Nov 26 11:22:49 EST 2025 Thu May 22 21:23:37 EDT 2025 Mon Jul 21 06:08:15 EDT 2025 Tue Nov 18 22:28:46 EST 2025 Sat Nov 29 06:34:29 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Language | English |
| License | Copyright: © 2022 Zagkos et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c642t-be4b0fd120c30771f4ae9919d8e6bc20a90790e4980dc0fdcb54d6312dd724f33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 I have read the journal’s policy and the authors of this manuscript have the following competing interests: DG is employed part-time by Novo Nordisk. VZ is a paid statistical consultant on PLOS Medicine’s statistical board. |
| ORCID | 0000-0001-7591-5684 0000-0003-2469-5516 0000-0002-1253-7556 0000-0001-8481-579X 0000-0001-6403-016X 0000-0001-7312-7078 0000-0002-4275-9328 0000-0002-7511-5684 0000-0002-7700-8102 0000-0002-8527-4873 |
| OpenAccessLink | https://doaj.org/article/17bf3b3fac81466c9746ce2d2c1cddcf |
| PMID | 36580444 |
| PQID | 2759264451 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_17bf3b3fac81466c9746ce2d2c1cddcf pubmedcentral_primary_oai_pubmedcentral_nih_gov_9799317 proquest_miscellaneous_2759264451 gale_infotracmisc_A733658088 gale_infotracgeneralonefile_A733658088 gale_infotracacademiconefile_A733658088 gale_incontextgauss_ISR_A733658088 gale_incontextgauss_ISN_A733658088 gale_incontextgauss_IOV_A733658088 gale_healthsolutions_A733658088 pubmed_primary_36580444 crossref_citationtrail_10_1371_journal_pmed_1004141 crossref_primary_10_1371_journal_pmed_1004141 |
| PublicationCentury | 2000 |
| PublicationDate | 20221229 |
| PublicationDateYYYYMMDD | 2022-12-29 |
| PublicationDate_xml | – month: 12 year: 2022 text: 20221229 day: 29 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco, CA USA |
| PublicationTitle | PLoS medicine |
| PublicationTitleAlternate | PLoS Med |
| PublicationYear | 2022 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | C. von Schacky (pmed.1004141.ref006) 2013; 18 DD Alexander (pmed.1004141.ref007) 2017; 92 Team RC. (pmed.1004141.ref034) 2020 pmed.1004141.ref037 V Zuber (pmed.1004141.ref032) 2020; 11 KL Fritsche (pmed.1004141.ref002) 2015; 6 EC Rizos (pmed.1004141.ref050) 2012; 308 TJ Brown (pmed.1004141.ref046) 2019; 366 WH Guan (pmed.1004141.ref012) 2014; 7 SNB Purcell (pmed.1004141.ref019) 2007 M Nikpay (pmed.1004141.ref022) 2015; 47 EC Rizos (pmed.1004141.ref004) 2021; 107 NL Tintle (pmed.1004141.ref015) 2015; 94 AC Skulas-Ray (pmed.1004141.ref045) 2019; 140 B Gray (pmed.1004141.ref042) 2013; 67 J Bowden (pmed.1004141.ref029) 2016; 40 CT Black LI (pmed.1004141.ref009) 2015; 10 FM Delpino (pmed.1004141.ref043) 2021; 44 CJ Tsai (pmed.1004141.ref039) 2004; 141 PC Calder (pmed.1004141.ref003) 2011; 668 L Yengo (pmed.1004141.ref021) 2018; 27 Y Benjamini (pmed.1004141.ref026) 1995; 57 EM Agency (pmed.1004141.ref044) 2019 N Soranzo (pmed.1004141.ref024) 2010; 59 JK Kim (pmed.1004141.ref041) 2012; 27 RJ Carroll (pmed.1004141.ref035) 2014; 30 C Sudlow (pmed.1004141.ref016) 2015; 12 J Kettunen (pmed.1004141.ref020) 2016; 7 E Sanderson (pmed.1004141.ref033) 2019; 48 S Burgess (pmed.1004141.ref027) 2013; 37 JH Wu (pmed.1004141.ref013) 2013; 6 F Berr (pmed.1004141.ref040) 1992; 16 M Marklund (pmed.1004141.ref052) 2019; 139 JC Lambert (pmed.1004141.ref023) 2013; 45 MC Borges (pmed.1004141.ref051) 2022; 20 S Burgess (pmed.1004141.ref031) 2015; 181 Schizophrenia Working Group of the Psychiatric Genomics C (pmed.1004141.ref038) 2015; 47 E Rajaei (pmed.1004141.ref048) 2015; 8 A Mahajan (pmed.1004141.ref025) 2014; 46 RN Lemaitre (pmed.1004141.ref011) 2011; 7 J Bowden (pmed.1004141.ref028) 2015; 44 G Markozannes (pmed.1004141.ref005) 2022; 41 TC Clarke (pmed.1004141.ref010) 2015; 75 B Elsworth (pmed.1004141.ref018) 2020 K Nagy (pmed.1004141.ref001) 2017 LL O’Mahoney (pmed.1004141.ref008) 2018; 17 L Hooper (pmed.1004141.ref053) 2018 G Hemani (pmed.1004141.ref036) 2018; 7 C Bycroft (pmed.1004141.ref017) 2018; 562 SY Shin (pmed.1004141.ref014) 2014; 46 A Sekikawa (pmed.1004141.ref049) 2019; 11 M Verbanck (pmed.1004141.ref030) 2018; 50 AE Naini (pmed.1004141.ref047) 2015; 4 |
| References_xml | – volume: 8 start-page: 18 issue: 7 year: 2015 ident: pmed.1004141.ref048 article-title: The Effect of Omega-3 Fatty Acids in Patients With Active Rheumatoid Arthritis Receiving DMARDs Therapy: Double-Blind Randomized Controlled Trial publication-title: Global J Health Sci doi: 10.5539/gjhs.v8n7p18 – ident: pmed.1004141.ref037 – volume: 668 start-page: S50 issue: Suppl 1 year: 2011 ident: pmed.1004141.ref003 article-title: Fatty acids and inflammation: the cutting edge between food and pharma publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2011.05.085 – volume: 17 start-page: 98 issue: 1 year: 2018 ident: pmed.1004141.ref008 article-title: Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-018-0740-x – volume: 41 start-page: 923 issue: 4 year: 2022 ident: pmed.1004141.ref005 article-title: Dose-related meta-analysis for Omega-3 fatty acids supplementation on major adverse cardiovascular events. publication-title: Clin Nutr. doi: 10.1016/j.clnu.2022.02.022 – volume: 27 start-page: 3641 issue: 20 year: 2018 ident: pmed.1004141.ref021 article-title: Meta-analysis of genome-wide association studies for height and body mass index in approximately 700000 individuals of European ancestry publication-title: Hum Mol Genet doi: 10.1093/hmg/ddy271 – volume: 139 start-page: 2422 issue: 21 year: 2019 ident: pmed.1004141.ref052 article-title: Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality: An Individual-Level Pooled Analysis of 30 Cohort Studies. publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.038908 – volume: 11 start-page: 29 issue: 1 year: 2020 ident: pmed.1004141.ref032 article-title: Selecting likely causal risk factors from high-throughput experiments using multivariable Mendelian randomization. publication-title: Nat Commun. doi: 10.1038/s41467-019-13870-3 – year: 2019 ident: pmed.1004141.ref044 publication-title: EMA confirms omega-3 fatty acid medicines are not effective in preventing further heart problems after a heart attack. – volume: 46 start-page: 543 issue: 6 year: 2014 ident: pmed.1004141.ref014 article-title: An atlas of genetic influences on human blood metabolites publication-title: Nat Genet doi: 10.1038/ng.2982 – volume: 562 start-page: 203 issue: 7726 year: 2018 ident: pmed.1004141.ref017 article-title: The UK Biobank resource with deep phenotyping and genomic data publication-title: Nature doi: 10.1038/s41586-018-0579-z – volume: 50 start-page: 693 issue: 5 year: 2018 ident: pmed.1004141.ref030 article-title: Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases publication-title: Nat Genet doi: 10.1038/s41588-018-0099-7 – volume: 59 start-page: 3229 issue: 12 year: 2010 ident: pmed.1004141.ref024 article-title: Common Variants at 10 Genomic Loci Influence Hemoglobin A(1C) Levels via Glycemic and Nonglycemic Pathways. publication-title: Diabetes doi: 10.2337/db10-0502 – volume: 67 start-page: 1234 issue: 12 year: 2013 ident: pmed.1004141.ref042 article-title: Omega-3 fatty acids: a review of the effects on adiponectin and leptin and potential implications for obesity management. publication-title: Eur J Clin Nutr doi: 10.1038/ejcn.2013.197 – volume: 11 issue: 11 year: 2019 ident: pmed.1004141.ref049 article-title: Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. publication-title: Nutrients doi: 10.3390/nu11112599 – volume: 7 start-page: 321 issue: 3 year: 2014 ident: pmed.1004141.ref012 article-title: Genome-Wide Association Study of Plasma N6 Polyunsaturated Fatty Acids Within the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. publication-title: Circ-Cardiovasc Gene doi: 10.1161/CIRCGENETICS.113.000208 – volume: 27 start-page: 1745 issue: 11 year: 2012 ident: pmed.1004141.ref041 article-title: N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice publication-title: J Gastroenterol Hepatol doi: 10.1111/j.1440-1746.2012.07227.x – volume: 7 start-page: 11122 year: 2016 ident: pmed.1004141.ref020 article-title: Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA. publication-title: Nat Commun. doi: 10.1038/ncomms11122 – volume: 18 start-page: e33 issue: 4 year: 2013 ident: pmed.1004141.ref006 article-title: Meta-analysing randomised controlled trials with omega-3 fatty acids in cardiovascular disease. publication-title: Evid Based Med doi: 10.1136/eb-2012-100960 – volume: 7 year: 2018 ident: pmed.1004141.ref036 article-title: The MR-Base platform supports systematic causal inference across the human phenome. publication-title: Elife doi: 10.7554/eLife.34408 – volume: 7 start-page: e1002193 issue: 7 year: 2011 ident: pmed.1004141.ref011 article-title: Genetic loci associated with plasma phospholipid n-3 fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium. publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1002193 – volume: 46 start-page: 234 issue: 3 year: 2014 ident: pmed.1004141.ref025 article-title: Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility publication-title: Nat Genet doi: 10.1038/ng.2897 – volume: 44 start-page: 512 issue: 2 year: 2015 ident: pmed.1004141.ref028 article-title: Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. publication-title: Int J Epidemiol doi: 10.1093/ije/dyv080 – volume-title: R: A language and environment for statistical computing year: 2020 ident: pmed.1004141.ref034 – volume: 141 start-page: 514 issue: 7 year: 2004 ident: pmed.1004141.ref039 article-title: The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men—A prospective cohort study publication-title: Ann Intern Med doi: 10.7326/0003-4819-141-7-200410050-00007 – volume: 48 start-page: 713 issue: 3 year: 2019 ident: pmed.1004141.ref033 article-title: An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings. publication-title: Int J Epidemiol doi: 10.1093/ije/dyy262 – volume: 4 start-page: 135 issue: 3 year: 2015 ident: pmed.1004141.ref047 article-title: Effect of Omega-3 fatty acids on blood pressure and serum lipids in continuous ambulatory peritoneal dialysis patients publication-title: J Res Pharm Pract doi: 10.4103/2279-042X.162356 – volume: 12 start-page: e1001779 issue: 3 year: 2015 ident: pmed.1004141.ref016 article-title: UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. publication-title: PLoS Med. doi: 10.1371/journal.pmed.1001779 – year: 2017 ident: pmed.1004141.ref001 publication-title: Importance of Fatty Acids in Physiopathology of Human Body – volume: 107 start-page: 150 issue: 2 year: 2021 ident: pmed.1004141.ref004 article-title: Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis publication-title: Heart doi: 10.1136/heartjnl-2020-316780 – volume: 57 start-page: 289 issue: 1 year: 1995 ident: pmed.1004141.ref026 article-title: Controlling the False Discovery Rate—a Practical and Powerful Approach to Multiple Testing. publication-title: J R Stat Soc B doi: 10.1111/j.2517-6161.1995.tb02031.x – volume: 366 year: 2019 ident: pmed.1004141.ref046 article-title: Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials publication-title: Bmj-Brit Med J – volume: 140 start-page: E673 issue: 12 year: 2019 ident: pmed.1004141.ref045 article-title: Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association publication-title: Circulation – volume: 94 start-page: 65 year: 2015 ident: pmed.1004141.ref015 article-title: A genome-wide association study of saturated, mono- and polyunsaturated red blood cell fatty acids in the Framingham Heart Offspring Study publication-title: Prostaglandins Leukot Essent Fatty Acids doi: 10.1016/j.plefa.2014.11.007 – volume: 6 start-page: 293S issue: 3 year: 2015 ident: pmed.1004141.ref002 article-title: The science of fatty acids and inflammation publication-title: Adv Nutr doi: 10.3945/an.114.006940 – volume: 6 start-page: 171 issue: 2 year: 2013 ident: pmed.1004141.ref013 article-title: Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium. publication-title: Circ Cardiovasc Genet. doi: 10.1161/CIRCGENETICS.112.964619 – year: 2007 ident: pmed.1004141.ref019 article-title: PLINK: a toolset for whole-genome association and population-based linkage analysis publication-title: Am J Hum Genet – issue: 11 year: 2018 ident: pmed.1004141.ref053 article-title: Omega-6 fats for the primary and secondary prevention of cardiovascular disease. publication-title: Cochrane Db Syst Rev. – volume: 30 start-page: 2375 issue: 16 year: 2014 ident: pmed.1004141.ref035 article-title: R PheWAS: data analysis and plotting tools for phenome-wide association studies in the R environment publication-title: Bioinformatics doi: 10.1093/bioinformatics/btu197 – volume: 44 start-page: 122 year: 2021 ident: pmed.1004141.ref043 article-title: Effects of omega-3 supplementation on body weight and body fat mass: A systematic review. publication-title: Clinical Nutrition Espen doi: 10.1016/j.clnesp.2021.04.023 – volume: 92 start-page: 15 issue: 1 year: 2017 ident: pmed.1004141.ref007 article-title: A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk publication-title: Mayo Clin Proc doi: 10.1016/j.mayocp.2016.10.018 – volume: 75 year: 2015 ident: pmed.1004141.ref010 article-title: The use of complementary health approaches among US cancer survivors publication-title: Cancer Res doi: 10.1158/1538-7445.AM2015-3723 – volume: 45 start-page: 1452 issue: 12 year: 2013 ident: pmed.1004141.ref023 article-title: Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease publication-title: Nat Genet doi: 10.1038/ng.2802 – volume: 40 start-page: 304 issue: 4 year: 2016 ident: pmed.1004141.ref029 article-title: Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator publication-title: Genet Epidemiol doi: 10.1002/gepi.21965 – volume: 308 start-page: 1024 issue: 10 year: 2012 ident: pmed.1004141.ref050 article-title: Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis publication-title: JAMA doi: 10.1001/2012.jama.11374 – volume: 181 start-page: 290 issue: 4 year: 2015 ident: pmed.1004141.ref031 article-title: Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects publication-title: Am J Epidemiol doi: 10.1093/aje/kwv017 – year: 2020 ident: pmed.1004141.ref018 article-title: The MRC IEU OpenGWAS data infrastructure. publication-title: BioRxiv [preprint]. – volume: 47 start-page: 1121 issue: 10 year: 2015 ident: pmed.1004141.ref022 article-title: A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease publication-title: Nat Genet doi: 10.1038/ng.3396 – volume: 20 issue: 1 year: 2022 ident: pmed.1004141.ref051 article-title: Role of circulating polyunsaturated fatty acids on cardiovascular diseases risk: analysis using Mendelian randomization and fatty acid genetic association data from over 114,000 UK Biobank participants. publication-title: BMC Med. doi: 10.1186/s12916-022-02399-w – volume: 47 start-page: 291 issue: 3 year: 2015 ident: pmed.1004141.ref038 article-title: LD Score regression distinguishes confounding from polygenicity in genome-wide association studies publication-title: Nat Genet doi: 10.1038/ng.3211 – volume: 16 start-page: 960 issue: 4 year: 1992 ident: pmed.1004141.ref040 article-title: Dietary N-3 Polyunsaturated Fatty-Acids Decrease Biliary Cholesterol Saturation in Gallstone Disease publication-title: Hepatology doi: 10.1002/hep.1840160418 – volume: 37 start-page: 658 issue: 7 year: 2013 ident: pmed.1004141.ref027 article-title: Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data publication-title: Genet Epidemiol doi: 10.1002/gepi.21758 – volume: 10 start-page: 1 issue: 78 year: 2015 ident: pmed.1004141.ref009 article-title: Use of complementary health approaches among children aged 4–17 years in the United States: National Health Interview Survey. publication-title: Natl Health Stat Rep. |
| SSID | ssj0029090 |
| Score | 2.5593424 |
| Snippet | Fatty acids are important dietary factors that have been extensively studied for their implication in health and disease. Evidence from epidemiological studies... Background Fatty acids are important dietary factors that have been extensively studied for their implication in health and disease. Evidence from... Loukas Zagkos and colleagues conduct Mendelian randomisation analysis to investigate potential causal associations of circulating fatty acids and 845 disease... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e1004141 |
| SubjectTerms | Adult Aged Analysis Bayes Theorem Biology and Life Sciences Cholecystitis - epidemiology Cholecystitis - genetics Cholelithiasis - epidemiology Cholelithiasis - genetics Coronary Disease - epidemiology Coronary Disease - genetics Coronary heart disease Docosahexaenoic Acids - blood Docosahexaenoic Acids - genetics Epidemiology Fatty Acids, Omega-3 - blood Fatty Acids, Omega-3 - genetics Fatty Acids, Omega-6 - blood Fatty Acids, Omega-6 - genetics Female Gallstones Genetic aspects Genetic Predisposition to Disease Genetics Health aspects Humans Male Medical research Medicine and Health Sciences Medicine, Experimental Mendelian Randomization Analysis - methods Middle Aged Obesity Obesity - epidemiology Obesity - genetics Omega-3 fatty acids Prevention Risk factors Unsaturated fatty acids |
| Title | Associations of genetically predicted fatty acid levels across the phenome: A mendelian randomisation study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36580444 https://www.proquest.com/docview/2759264451 https://pubmed.ncbi.nlm.nih.gov/PMC9799317 https://doaj.org/article/17bf3b3fac81466c9746ce2d2c1cddcf |
| Volume | 19 |
| WOSCitedRecordID | wos000924510300011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: DOA dateStart: 20040101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: 7X7 dateStart: 20041001 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: BENPR dateStart: 20041001 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: PIMPY dateStart: 20041001 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVATS databaseName: Public Library of Science (PLoS) Journals Open Access customDbUrl: eissn: 1549-1676 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0029090 issn: 1549-1676 databaseCode: FPL dateStart: 20040101 isFulltext: true titleUrlDefault: http://www.plos.org/publications/ providerName: Public Library of Science |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdgIMQL4pvCKAYheMoWJ26d8NahVUzaSjU-VJ6s-GtUtEnVtEj777lz3KoRSNsDL1EU_yIld2f7zr77mZC31oDknYLoJO2piOvERHlmisimwjqeqVgzXyh8KkajbDLJxztHfWFOWEMP3AjukAnlUpW6QuNiVV-D_4uHWJlEM22Mdjj6gtezCaZCqJXHfnUF-ccilggRiuZSwQ6Djg4WMNtgjgBnnLUmJc_d__cIvTNFtdMnd-aj4X1yLziSdND8wANyw5YPyZ2zsFX-iPzaEXxNK0fBUpqCxdklXSwRB84mdcVqdUkLPTV0hvlDNdzjN1JwDCnmf1Vz-4EO6ByXynFJhMLkZqp5yAKinp72Mfk2PP768VMUTlaINMQbq0hZrmJnWBJr6OOCOV5YcBRzk9m-0klcQMicx5bnWWw0ALXqcdNPWWKMSLhL0ydkr6xK-4xQBQ6d4wq8hkxDrOaywvIEg5Csb_s9Zjok3YhW6kA7jqdfzKTfSxMQfjQCk6gQGRTSIdH2rUVDu3EF_gi1tsUiabZ_AKYkgynJq0ypQ16hzmVTgbrt-nKAlJG9DMbjDnnjEUicUWJmzkWxrmt58vn7NUBfRtcBnbdA7wPIVSAzXYSSCZA8sna1kO9ayIuGs_xfwP0WEMxFt5pfb-xdYhNm4JW2WtcSdJqj89wDWT9t7H8rbf8y57xDRKtntNTRbimnPz2XOe4qgwv7_H_o7wW5m2BxCkuiJN8ne6vl2r4kt_Xv1bRedslNMRH-mnXJraPj0fi86wcNuA7Hp_BsfHI2_vEH6qd0nw |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Associations+of+genetically+predicted+fatty+acid+levels+across+the+phenome%3A+A+mendelian+randomisation+study&rft.jtitle=PLoS+medicine&rft.au=Zagkos%2C+Loukas&rft.au=Dib%2C+Marie-Joe&rft.au=Pinto%2C+Rui&rft.au=Gill%2C+Dipender&rft.date=2022-12-29&rft.issn=1549-1676&rft.eissn=1549-1676&rft.volume=19&rft.issue=12&rft.spage=e1004141&rft_id=info:doi/10.1371%2Fjournal.pmed.1004141&rft.externalDBID=n%2Fa&rft.externalDocID=10_1371_journal_pmed_1004141 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-1676&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-1676&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-1676&client=summon |